Anti-Vascular Endothelial Growth Factor (VEGF)

    Anti-Vascular Endothelial Growth Factor Treatment for Retinal Conditions: A Systematic Review and Meta-analysis

    Impact:

    • The results of this review were used by the Canadian Drug Expert Committee to inform recommendations for Canadian policymakers regarding the reimbursement of anti-VEGF agents

    Protocol:

    Additional Resources:

    Funding:

    Canadian Institutes of Health Research (CIHR)/ Drug Safety and Effectiveness Network (DSEN) and Canadian Agency for Drugs and Technology in Health (CADTH)


    Anti-Vascular Endothelial Growth Factor Therapy for neovascular Age-related Macular Degeneration: Systematic Review and Network Meta-analysis

    Impact:

    • Will provide healthcare providers and policy-makers with evidence on the safety of these agents for their decision-making

    Protocol:

    Additional Resources:

    Funding:

    Canadian Institutes of Health Research (CIHR)/Drug Safety and Effectiveness Network (DSEN) and Canadian Agency for Drugs and Technology in Health (CADTH)

    Category :

    Date : 25 Aug 2017